BSEBoard MeetingResults23 Jul 2026
Solara Active Pharma Sciences Ltd
Solara Active Pharma Sciences Limited has informed the exchange regarding, inter alia, to consider and approve the unaudited Standalone and Consolidated Financial Results for the quarter ....
Solara Active Pharma Sciences Ltd has informed the exchange about the outcome of their board meeting held on July 23, 2026, where they considered and approved the unaudited financial results for the quarter ended June 30, 2026.
BSECompany Update▲ PositiveRating Change23 Jun 2026
Solara Active Pharma Sciences Ltd
Solara Active Pharma Sciences Limited has informed the Stock Exchange regarding Credit Rating received from Crisil Ratings Limited
Solara Active Pharma Sciences Ltd has announced that Crisil Ratings Limited has upgraded its credit ratings for bank loan facilities totaling Rs. 791.2 Crore. The long-term rating has been upgraded to 'Crisil BBB+/Stable' from 'Crisil BBB/Stable', and the short-term rating has improved to 'Crisil A2' from 'Crisil A3+'. This upgrade reflects an improvement in the company's creditworthiness and financial risk profile.